16S ribosomal RNA aminoacyl-tRNA site (A-site) (16S rRNA A-site)

The 16S ribosomal RNA aminoacyl-tRNA site (A-site) is a highly conserved and essential functional region within the 30S small ribosomal subunit of bacteria [1, 3]. Its primary biological role is the decoding of messenger RNA (mRNA) by facilitating the correct pairing between mRNA codons and incoming aminoacyl-tRNA molecules [3, 10]. During translation, the A-site monitors the fidelity of this interaction, ensuring that only the cognate tRNA is accepted for peptide bond formation [8, 10]. This site is a major therapeutic target for several classes of broad-spectrum antibiotics, including aminoglycosides and tetracyclines [1, 13, 15]. Aminoglycosides, such as gentamicin and amikacin, bind with high affinity to the A-site, inducing a conformational change that causes the ribosome to misread the genetic code, leading to the production of aberrant proteins and bacterial cell death [1, 4, 5]. Tetracyclines also target this region but act by sterically blocking the attachment of aminoacyl-tRNA, thereby halting protein synthesis [14, 17]. While highly effective against bacterial pathogens, drugs targeting the 16S rRNA A-site can exhibit off-target effects on human mitochondrial ribosomes due to structural similarities, which may result in clinical toxicities such as ototoxicity and nephrotoxicity [3, 14].

Other names

Decoding site30S A-siteAminoacyl-tRNA site16S rRNA decoding centerAminoacyl-tRNA recognition site

Aminoglycosides bind to the 16S rRNA A-site, inducing a conformational change in nucleotides A1492 and A1493 that promotes codon misreading and mistranslation, leading to the synthesis of non-functional or toxic proteins [1, 4, 5]. Tetracyclines bind to the same site to sterically block the entry of aminoacyl-tRNA into the ribosome, thereby inhibiting the elongation phase of protein synthesis [14, 17].